Literature DB >> 9341762

Size-dependent effect of IgA on the IgA Fc receptor (CD89).

T J Reterink1, G van Zandbergen, M van Egmond, N Klar-Mohamad, C H Morton, J G van de Winkel, M R Daha.   

Abstract

The IgA Fc receptor (FcR; CD89) is expressed on several types of cells of the myeloid cell lineage. We investigated whether different sizes of heat-aggregated IgA (aIgA) bind to CD89 and subsequently induce cellular activation. As a model we used the murine B cell line IIA1.6 transfected with CD89 or IIA1.6 cells transfected with CD89 as well as with the FcR gamma chain to study the binding of IgA to CD89. When these cells expressing CD89 were incubated with monomeric IgA, no significant binding of IgA to the cells was detectable by fluorescence-activated cell sorter analysis; however, incubation of the cells with aggregated IgA resulted in 93 +/- 2% positive cells. Incubation of the cells with different sizes of IgA-containing aggregates revealed optimal binding with aggregates containing five to six molecules of IgA per aggregate. No difference was observed between the binding to CD89 of both IgA1- or IgA2-containing aggregates. Furthermore, the binding of aIgA was found to be CD89-specific, since the binding of IgA was completely inhibited by the CD89-specific monoclonal antibody My43 and no detectable binding occurred to the IIA1.6 parent cell line. Activation studies using interleukin-2 (IL-2) production as a marker, showed that the FcR gamma chain is necessary to induce cellular activation. Only cells transfected with both CD89 and the FcR gamma chain (CD89+/gamma +) enhance the IL-2 production 10-12-fold upon stimulation with aggregates of IgA. Furthermore, triggering of CD89 only results in increase of intracellular calcium concentration ([Ca2+]i) in cells co-expressing FcR gamma chain. Mutation of the tyrosine residues in the FcR gamma chain immunoreceptor tyrosine-based activation motif of the FcR gamma chain abolishes this increase in [Ca2+]i, indicating association and involvement of the FcR gamma chain in CD89-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341762     DOI: 10.1002/eji.1830270915

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors.

Authors:  Mélanie Duc; Finn-Eirik Johansen; Blaise Corthésy
Journal:  J Biol Chem       Date:  2009-11-12       Impact factor: 5.157

Review 2.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

Review 3.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

4.  Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.

Authors:  K Olas; H Butterweck; W Teschner; H P Schwarz; B Reipert
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

5.  Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate.

Authors:  J A G van Roon; J W J Bijlsma; J G J van de Winkel; F P J G Lafeber
Journal:  Ann Rheum Dis       Date:  2004-11-11       Impact factor: 19.103

6.  Serological Measurement of Poly-IgA Immune Complex Levels in IgA Nephropathy and IgA Vasculitis.

Authors:  Xue Zhang; Jicheng Lv; Pan Liu; Xinfang Xie; Xinyan Li; Hong Zhang; Jing Jin
Journal:  Bio Protoc       Date:  2022-07-05

7.  Poly-IgA Complexes and Disease Severity in IgA Nephropathy.

Authors:  Xue Zhang; Jicheng Lv; Pan Liu; Xinfang Xie; Manliu Wang; Dan Liu; Hong Zhang; Jing Jin
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-04       Impact factor: 8.237

8.  Immunoglobulin-binding sites of human FcalphaRI (CD89) and bovine Fcgamma2R are located in their membrane-distal extracellular domains.

Authors:  H C Morton; G van Zandbergen; C van Kooten; C J Howard; J G van de Winkel; P Brandtzaeg
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

9.  Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities.

Authors:  Swamy Kumar Polumuri; Lydia A Haile; Derek D C Ireland; Daniela Verthelyi
Journal:  Sci Rep       Date:  2018-07-31       Impact factor: 4.379

Review 10.  The inflammatory function of human IgA.

Authors:  Ivo S Hansen; Dominique L P Baeten; Jeroen den Dunnen
Journal:  Cell Mol Life Sci       Date:  2018-11-29       Impact factor: 9.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.